A detailed history of Copperwynd Financial, LLC transactions in Incyte Corp stock. As of the latest transaction made, Copperwynd Financial, LLC holds 12,960 shares of INCY stock, worth $1.35 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
12,960
Previous 12,747 1.67%
Holding current value
$1.35 Million
Previous $771,000 14.4%
% of portfolio
0.22%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 23, 2025

BUY
$55.17 - $71.22 $11,751 - $15,169
213 Added 1.67%
12,960 $882,000
Q1 2025

May 05, 2025

BUY
$60.0 - $75.26 $28,560 - $35,823
476 Added 3.88%
12,747 $771,000
Q4 2024

Feb 10, 2025

SELL
$65.08 - $83.38 $8,135 - $10,422
-125 Reduced 1.01%
12,271 $847,000
Q3 2024

Nov 04, 2024

BUY
$57.33 - $68.61 $710,662 - $850,489
12,396 New
12,396 $819,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Copperwynd Financial, LLC Portfolio

Follow Copperwynd Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copperwynd Financial, LLC with notifications on news.